BindingDB logo
myBDB logout

36 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
26670264 73 Fragment-Based Discovery of 2-Aminoquinazolin-4(3H)-ones As Novel Class Nonpeptidomimetic Inhibitors of the Plasmepsins I, II, and IV.EBI Latvian Institute of Organic Synthesis
26188621 2 Chalcone scaffolds as anti-infective agents: structural and molecular target perspectives.EBI Guru Ghasidas Vishwavidyalaya (A Central University)
24631188 12 Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum.EBI Kyoto Pharmaceutical University
23466235 5 Discovery of non-peptide inhibitors of Plasmepsin II by structure-based virtual screening.EBI East China University of Science and Technology
22884991 9 Antiplasmodial activities of 4-aminoquinoline-statine compounds.EBI Universit£ degli Studi di Milano
18417344 6 Identification of acridinyl hydrazides as potent aspartic protease inhibitors.EBI University of Karachi
15139758 50 Incorporating molecular shape into the alignment-free Grid-Independent Descriptors.EBI Universitat Pompeu Fabra
10669559 180 Protease inhibitors: current status and future prospects.EBI University of Queensland
15125962 9 Plasmepsin II inhibition and antiplasmodial activity of Primaquine-Statine 'double-drugs'.EBI University of Milan
9873534 36 Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library.EBI Pharmacopeia, Inc.
22204908 22 New benzimidazole derivatives as antiplasmodial agents and plasmepsin inhibitors: synthesis and analysis of structure-activity relationships.EBI University of Karachi
21531557 16 Identification of plasmepsin inhibitors as selective anti-malarial agents using ligand based drug design.EBI Trinity College
20466465 1 Quinolines and structurally related heterocycles as antimalarials.EBI National Institute of Pharmaceutical Education and Research
20634066 13 Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution.EBI Kyoto Pharmaceutical University
20438064 14 Mechanism-based inhibitors of the aspartyl protease plasmepsin II as potential antimalarial agents.EBI Wayne State University
19635672 35 alpha-Substituted norstatines as the transition-state mimic in inhibitors of multiple digestive vacuole malaria aspartic proteases.EBI Uppsala University
19361896 5 Recent developments in the design and synthesis of hybrid molecules based on aminoquinoline ring and their antiplasmodial evaluation.EBI Universidad Industrial de Santander
19328682 13 Expedient solid-phase synthesis of both symmetric and asymmetric diol libraries targeting aspartic proteases.EBI National University of Singapore
18952439 34 Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.EBI Kyoto Pharmaceutical University
11975483 10 New antiinfective and human 5-HT2 receptor binding natural and semisynthetic compounds from the Jamaican sponge Smenospongia aurea.EBI The University of Mississippi
17400453 17 Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin II.EBI Kyoto Pharmaceutical University
17149873 20 High antiplasmodial activity of novel plasmepsins I and II inhibitors.EBI University of Milan
17000102 56 Inhibitors of Plasmepsin II-potential antimalarial agents.EBI Actelion Pharmaceuticals Ltd
16162010 78 Synthesis of malarial plasmepsin inhibitors and prediction of binding modes by molecular dynamics simulations.EBI Uppsala University
15974592 68 Design and synthesis of potent inhibitors of plasmepsin I and II: X-ray crystal structure of inhibitor in complex with plasmepsin II.EBI Linköping University
10212129 20 Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II.EBI University of California
9873703 4 Evaluation of a structure-based statine cyclic diamino amide encoded combinatorial library against plasmepsin II and cathepsin D.EBI Pharmacopeia, Inc.
20063996 12 Characterisation of hydrazides and hydrazine derivatives as novel aspartic protease inhibitors.BDB University of Karachi
18760609 66 Achiral oligoamines as versatile tool for the development of aspartic protease inhibitors.BDB Philipps-University Marburg
12857114 102 High-speed optimization of inhibitors of the malarial proteases plasmepsin I and II.BDB Uppsala University
12593654 48 Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytes.BDB Uppsala University
14695825 67 Potent inhibitors of the Plasmodium falciparum enzymes plasmepsin I and II devoid of cathepsin D inhibitory activity.BDB Uppsala University
15189032 66 Design and synthesis of potent inhibitors of the malaria aspartyl proteases plasmepsin I and II. Use of solid-phase synthesis to explore novel statine motifs.BDB Linkoping University